October 1956
American Journal of Gastroenterology;Oct1956, Vol. 26 Issue 4, p469
Academic Journal
Investigates the role of the combination of anticholinergic and surface anesthetics in Dactil as a factor in the treatment of upper gastrointestinal tract disease. Efficacy of the drugs; Observation of the side reaction of the drugs among patients; Response of patients to the medical management in gastric ulcers.


Related Articles

  • CLINICAL OBSERVATIONS WITH A NEW ANTICHOLINERGIC, GLYCOPYRROLATE. Epstein, Jerome H. // American Journal of Gastroenterology;Mar1962, Vol. 37 Issue 3, p295 

    Presents a study on the efficacy of the anticholinergic agent glycopyrrolate for the treatment of patients with gastrointestinal disorders. Clinical results; Average dosage of the agent; Side-effects of the agent.

  • Asthma pathophysiology and evidence-based treatment of severe exacerbations. Schreck, David M. // American Journal of Health-System Pharmacy;5/15/2006 Supplement, Vol. 63, pS5 

    Purpose. The pathogenesis of asthma and the treatment approach for acute exacerbations are described. The pharmacology, efficacy, safety, and cost of the β2 agonist, albuterol, a racemic mixture of equal amounts of R- and S-enantiomers, and levalbuterol, the R-enantiomer, are compared....

  • HEXOCYCLIUM (TRAL) IN THE TREATMENT OF PEPTIC ULCER AND ITS EFFECT ON HUMAN GASTRIC SECRETION. Rider, J. Alfred; Gibbs, John O.; Meikle, Maureen; Agcaioli, Lourdes F.; Anderegg, Alfred F.; Moeller, Hugo C.; Swader, Joyce // American Journal of Gastroenterology;May1958, Vol. 29 Issue 5, p524 

    Tral is a new anticholinergic compound, the properties of which have been well demonstrated by pharmacologic studies in experimental animals. A suppressive action on the basal gastric secretion was noted in two groups of 17 subjects each after single oral doses of 25 mg. and 50 mg. of the drug....

  • Comparison of gastric peristalsis inhibition by scopolamine butylbromide and glucagon: evaluation by electrogastrography and analysis of heart rate variability. Katoh, Kansei; Nomura, Masahiro; Iga, Akiko; Hiasa, Aya; Uehara, Kohzou; Harada, Kenji; Nakaya, Yutaka; Ito, Susumu // Journal of Gastroenterology;2003, Vol. 38 Issue 7, p629 

    Compares the inhibitory effects of anticholinergic drugs scopolamine butylbromide and glucagon on gastric peristalsis. Heart rate variability; Electrogastrography; Blood catecholamine levels; Absence of effect on autonomic nervous activity.

  • Effects of penehyclidine hydrochloride on the propofol dose requirement and Bispectral Index for loss of consciousness. Peng Liang; Yanju Zhang; Hai Yu; Bin Liu // International Journal of Clinical & Experimental Medicine;2014, Vol. 7 Issue 8, p2236 

    Penehyclidine hydrochloride (PH), a new anticholinergic drug associated with few cardiovascular side effects, was used widely as premedication in China. There is no information on the pharmacodynamic interaction between PH and anesthetics for loss of consciousness (LOC). This study was designed...

  • SECTION 9: GASTROINTESTINAL.  // Nurse Practitioners Prescribing Reference;Summer2009, Vol. 16 Issue 2, p140 

    The article provides information on various drugs that are useful for treating different kinds of gastrointestinal tract diseases in the U.S. It states that Amoxil is used to treat Helicobacter pylori in adults with duodenal ulcer to be taken every 12 hours for 14 days. Meanwhile, Levsin is used...

  • Antacids and Anticholinergic Drug. Littman, Armand; Pine, Brian H. // Annals of Internal Medicine;Apr75, Vol. 82 Issue 4, p544 

    Discusses the effectiveness of antacids and anticholinergic drugs in gastrointestinal disease treatment. Mode of action of antacids; Use of antacid in the treatment of peptic ulcer; Effect of anticholinergic drugs on acid contents of the stomach; Effectiveness of anticholinergic drugs in peptic...

  • Therapeutic Gains of Prolonged Bronchial Dilatation in Chronic Obstructive Pulmonary Disease. Turino, Gerard M. // Annals of Internal Medicine;9/6/2005, Vol. 143 Issue 5, p386 

    Presents information on therapeutic gains of prolonged bronchial dilatation in chronic obstructive pulmonary disease (COPD). Examination of the clinical spectrum of COPD; Symptoms of COPD; Effectiveness of the anticholinergic bronchodilator tiotropium in the treatment of COPD; Mechanisms by...

  • Nonpharmacologic vs. Anticholinergic Therapies for Overactive Bladder. Kripke, Clarissa // American Family Physician;5/1/2007, Vol. 75 Issue 9, p1336 

    The article compares nonpharmacologic therapies with anticholinergic medications in patients with overactive bladder. It stresses that a combination of an anticholinergic agent and bladder training is more effective than either therapy alone. Causes of chronic bladder irritation are cited,...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics